Anticoagulation in new-onset postoperative atrial fibrillation: An analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database

Authors: Fady S. Riad, Maria V. Grau‐Sepulveda, Oliver K. Jawitz, Andrew M. Vekstein, Varun Sundaram, Jayakumar Sahadevan, Robert Habib, Jeffrey P. Jacobs, Sean M. O’Brien, Vinod H. Thourani, Sreekanth Vemulapalli, Ying Xian, Albert L. Waldo, Joseph F. Sabik - Heart Rhythm O2 2022 cited by 37

Background: New-onset postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery and is associated with increased long-term stroke and mortality. Anticoagulation has been suggested as a potential therapy, but data on safety and efficacy are scant. Objectives: To determine the association between anticoagulation for POAF and long-term outcomes. Methods: -VASc score was also assessed. Results: -VASc scores ≥5 compared to patients with scores of 2-4. Anticoagulation did not appear to benefit either subgroup. Conclusion: -VASc score.